L3VLUP
ProSign in

HCA · ELV in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

HCAELV
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • HCA
  • ELV
010203040202120222023202420252026
Holders and value by quarter
QuarterHCAELV
Q3 202026 holders, $8.6bn30 holders, $15.0bn
Q4 202029 holders, $12.3bn29 holders, $16.7bn
Q1 202118 holders, $13.3bn25 holders, $18.6bn
Q2 202119 holders, $13.9bn30 holders, $19.4bn
Q3 202128 holders, $15.8bn26 holders, $18.5bn
Q4 202125 holders, $16.0bn29 holders, $23.3bn
Q1 202222 holders, $13.8bn31 holders, $23.9bn
Q2 202228 holders, $7.8bn32 holders, $23.3bn
Q3 202224 holders, $8.4bn34 holders, $22.6bn
Q4 202220 holders, $10.5bn34 holders, $25.5bn
Q1 202325 holders, $11.0bn39 holders, $22.5bn
Q2 202326 holders, $11.3bn38 holders, $20.6bn
Q3 202327 holders, $8.1bn34 holders, $19.8bn
Q4 202328 holders, $9.0bn36 holders, $20.3bn
Q1 202425 holders, $10.6bn35 holders, $21.3bn
Q2 202423 holders, $9.8bn33 holders, $22.1bn
Q3 202425 holders, $11.5bn30 holders, $20.2bn
Q4 202428 holders, $8.1bn32 holders, $15.9bn
Q1 202520 holders, $8.7bn28 holders, $17.1bn
Q2 202520 holders, $9.4bn27 holders, $14.8bn
Q3 202520 holders, $9.9bn27 holders, $12.7bn
Q4 202522 holders, $11.4bn25 holders, $17.0bn
Q1 202623 holders, $10.3bn26 holders, $13.6bn
Q2 202621 holders, $7.1bn28 holders, $17.7bn
HCA

Hca Healthcare Inc

Holders
28
Reported value
$9.0bn
Buyers
17
Sellers
14

Breadth +3 among 93 comparable managers.

Health care services and research
ELV

Elevance Health Inc Formerly

Holders
36
Reported value
$20.3bn
Buyers
10
Sellers
27

Breadth -17 among 93 comparable managers.

Health care services and researchManaged care

Who holds both, Q4 2023

Among the 50 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only HCA (14)

Appaloosa LP, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Capital World Investors, Caxton Associates LLP, Farallon Capital Management LLC, GAMCO Investors Inc, Harris Associates LP, Holocene Advisors LP, Markel Group Inc, Scion Asset Management LLC, Tudor Investment Corp, Viking Global Investors LP, Woodline Partners LP

Only ELV (22)

Acadian Asset Management LLC, AQR Capital Management LLC, Artisan Partners LP, Baillie Gifford & Co, Citadel Advisors LLC, D. E. Shaw & Co., D1 Capital Partners LP, Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), Marshall Wace LLP, Maverick Capital Ltd, MFS Investment Management, Millennium Management LLC, Renaissance Technologies LLC, Ruane Cunniff & Goldfarb LP, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, Steadfast Capital Management LP, Two Sigma Advisers LP, Two Sigma Investments LP, Voloridge Investment Management LLC

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →